Saturday, April 16, 2022

mRNA vaccine for Epstein-Barr Virus enters Phase I trial.


 mRNA vaccine for Epstein-Barr Virus enters Phase I trial.

Visit: https://infectious.pencis.com/
Contact us: infectious@pencis.com

#infectiousdiseases #bacteriology #virology #microbiology #medicine #zikavirus #bacteria #epidemiology #immunology #diphtheria #vaccin #tuberculosis #treatment #infection #virus
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Biogenic Copper-Based Nanoparticles: Emerging Antimicrobial Agents Against Pathogenic Microorganisms | Nanomedicine & Infection Control #researchawards

Introduction Biogenic copper-based nanoparticles (CuNPs) have emerged as promising antimicrobial agents due to their potent activity and en...